Agrylin® Capsules 1 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

CompletedNCT00648765

Mylan Pharmaceuticals IncHealthy

Start: 2003-01-31End: 2003-01-31Updated: 2024-04-24

Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

CompletedNCT00648024

Mylan Pharmaceuticals IncHealthy

Start: 2003-01-31End: 2003-01-31Updated: 2024-04-24